Novartis seeks European approval of cell therapy Kymriah

on November 6th, 2017, 6:46am
ZURICH (Reuters) - Swiss drugmaker Novartis said on Monday it submitted an application for its cell therapy Kymriah to be approved in Europe for two forms of blood cancer.

Latest Life News

More Life News

Thousands march against coal ahead of climate conference in Bonn

FRANKFURT (Reuters) - Thousands of people took to the streets of Bonn on Saturday to call for the phasing out of coal as a source of power ahead of global talks on climate change in the German city next week.

4 Nov 2017

Paintings by Indian elephant auctioned off in Hungary

BUDAPEST (Reuters) - Paintings created by an Indian elephant who enjoys wielding a brush were auctioned off by a Hungarian traveling circus on Saturday.

4 Nov 2017

Pacific Tsunami Warning Center says no tsunami threat from quake

(Reuters) - An earthquake magnitude 6.9, depth 32 km, struck 192 km South West of Apia, Samoa, at 0900 GMT on Saturday, the U.S. Geological Survey said.

4 Nov 2017

Top News Videos